Zoledronic acid improves bone mineral density in pediatric spinal cord injury

Journal of Bone and Mineral Research

Volumn 27, Issue 7, 2012, Pages 1536-1540

  Ooi, Hooi Leng ^a   Briody, Julie ^a   McQuade, Mary ^a   Munns, Craig F ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Bone mineral density; Fracture; Osteoporosis; Spinal cord injury; Zoledronic acid

Indexed keywords

ZOLEDRONIC ACID;

ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; BONE STRENGTH; BONE TURNOVER; CASE REPORT; CHILD; CHILDHOOD INJURY; COMPUTER ASSISTED TOMOGRAPHY; DIAPHYSIS; DRUG EFFECT; DUAL ENERGY X RAY ABSORPTIOMETRY; FRAGILITY FRACTURE; HUMAN; HUMERUS FRACTURE; MALE; METAPHYSIS; MYELITIS; QUADRIPLEGIA; SCHOOL CHILD; SPINAL CORD INJURY; TRABECULAR BONE; TREATMENT DURATION;

BONE AND BONES; BONE DENSITY; CHILD; DENSITOMETRY; DIPHOSPHONATES; FRACTURES, BONE; HUMANS; IMIDAZOLES; MALE; MYELITIS, TRANSVERSE; OSTEOPOROSIS; SPINAL CORD INJURIES; TIBIA; TREATMENT OUTCOME;

EID: 84862491166     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.1598     Document Type: Article

References (24)

1. Jiang SD, Dai LY, Jiang LS. Osteoporosis after spinal cord injury. Osteoporos Int. 2006;17:180-92.
2. Warden SJ, Bennell KL, Matthews B, Brown DJ, McMeeken JM, Wark JD. Quantitative ultrasound assessment of acute bone loss following spinal cord injury: a longitudinal pilot study. Osteoporos Int. 2002;13:586-92. (Pubitemid 34790632)
3. Slade JM, Bickel CS, Modlesky CM, Majumdar S, Dudley GA. Trabecular bone is more deteriorated in spinal cord injured versus estrogenfree postmenopausal women. Osteoporos Int. 2005;16:263-72. (Pubitemid 40385038)
4. Modlesky CM, Majumdar S, Narasimhan A, Dudley GA. Trabecular bone microarchitecture is deteriorated in men with spinal cord injury. J Bone Miner Res. 2004;19:48-55. (Pubitemid 41295137)
5. Dauty M, Perrouin-Verbe B, Maugars Y, Dubois C, Mathie JF. Supralesional and sublesional bone mineral density in spinal cord-injured patients. Bone. 2000;27:305-9. (Pubitemid 30458827)
6. Jiang SD, Jiang LS, Dai LY. Mechanisms of osteoporosis in spinal cord injury. Clin Endocrinol. 2006;65:555-65.
7. Eser P, Frotzler A, Zehnder Y, Wicka L, Knechta H, Denothb J, Schiesslc H. Relationship between the duration of paralysis and bone structure: a pQCT study of spinal cord injured individuals. Bone. 2004;34: 869-80. (Pubitemid 38581133)
8. Bauman WA, Spungen AM, Wang J, Pierson RN, Schwartz E. Continuous loss of bone during chronic immobilization: a monozygotic twin study. Osteoporos Int. 1999;10:123-7. (Pubitemid 29462200)
9. Lazo MG, Shirazi P, Sam M, Giobbie-Hurder A, Blacconiere MJ, Muppidi M. Osteoporosis and risk of fracture in men with spinal cord injury. Spinal Cord. 2001;39:208-14. (Pubitemid 32574770)
10. Sniger W, Garshick E. Alendronate increases bone density in chronic spinal cord injury: a case report. Arch Phys Med Rehabil. 2002;83: 139-40. (Pubitemid 34052152)
11. Maïmoun L, Fattal C, Micallef J-P, Peruchon E, Rabischong P. Bone loss in spinal cord-injured patients: from physiopathology to therapy. Spinal Cord. 2006;44:203-10.
12. Bauman WA, Wecht JM, Kirshblum S, Spungen AM, Morrison N, Cirnigliaro C, Schwartz E. Effect of pamidronate administration on bone in patients with acute spinal cord injury. J Rehabil Res Dev. 2005;42:305-13. (Pubitemid 41105826)
13. Nance PW, Schryvers O, Leslie W, Ludwig S, Krahn J, Uebelhart D. Intravenous pamidronate attenuates bone density loss after acute spinal cord injury. Arch Phys Med Rehabil. 1999;80:243-51. (Pubitemid 29124741)
14. Gilchrist NL, Frampton CM, Acland RH, Nicholls MG, March RL, Maguire P, Heard A, Reilly P, Marshall K. Alendronate prevents bone loss in patients with acute spinal cord injury: a randomised, double-blind, placebo-controlled study. J Clin Endocrinol Metab. 2007;92:1385-90. (Pubitemid 46556414)
15. Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, BrintzenhofeSzoc K, Caminis J. Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int. 2007;80:316-22. (Pubitemid 46897445)
16. Bryson JE, Gourlay ML. Bisphosphonate use in acute and chronic spinal cord injury: a systematic review. J Spinal Cord Med. 2009;32:215-25.
17. Lu PW, Briody JN, Ogle GD, Morley K, Humphries IR, Allen J, Howman-Giles R, Sillence D, Cowell CT. Bone mineral density of total body, spine, and femoral neck in children and young adults: a cross-sectional and longitudinal study. J Bone Miner Res. 1994;9:1451-8. (Pubitemid 24268858)
18. Ogle GD, Allen JR, Humphries IR, Lu PW, Briody JN, Morley K, Howman-Giles R, Cowell CT. Body-composition assessment by dual-energy X-ray absorptiometry in subjects aged 4-26 y. Am J Clin Nutr. 1995;61:746-53.
19. Högler W, Briody J, Woodhead HJ, Chan A, Cowell CT. Importance of lean mass in the interpretation of total body densitometry in children and adolescents. J Pediatr. 2003;143:81-8. (Pubitemid 36928573)
20. Rauch F, Schonau E. Paediatric Reference pQCT data. J Musculoskelet Neuronal Interact. 2005;5:119-29.
21. Moyer-Mileur LJ, Quick JL, Murray MA. Peripheral quantitative computed tomography of the tibia: pediatric reference values. J Clin Densitom. 2008;11:283-94.
22. Rauch F, Travers R, Plotkin H, Glorieux FH. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest. 2002;110:1293-9. (Pubitemid 35285755)
23. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363:1377-85. (Pubitemid 38529880)
24. Bachrach LK, Ward LM. Clinical review: bisphosphonate use in childhood osteoporosis. J Clin Endocrinol Metab. 2009;94:400-9.